Global Spinal Cord Stimulation Market

Spinal Cord Stimulation Market Size, Share, Growth Analysis, By Indication (Failed Back Surgery Syndrome, Complex Regional Pain Syndrome), By Product (Rechargeable Devices, Non-Rechargeable Devices), By End User (Hospitals), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2711 | Region: Global | Published Date: February, 2024
Pages: 165 | Tables: 65 | Figures: 74

Spinal Cord Stimulation Market Dynamics

Spinal Cord Stimulation Market Drivers

Continuous technological advancements and government guidelines to favor the market growth.

  • The makers have intensified their research efforts in an effort to make spinal cord stimulators smaller. For instance, the Stimwave LCC-produced Freedom SCS system is roughly 5% smaller than the existing Implantable Pulse Generators (IPG) on the market. The rise of the spinal cord stimulation market is being driven by this as well as improvements in impulse production. 
  • One of the main drivers of market expansion is the development of recommendations for spinal cord stimulation therapy. Guidelines for this therapy's use in the treatment of chronic pain and other disease indications are being developed by a number of government associations. For instance, the Senza SCS system, which administers HF10 therapy to treat patients with neuropathic pain, was the subject of guidelines and recommendations released by the National Institute for Health and Care Excellence. Such encouraging proposals from governmental organizations are likely to increase market activity.

Spinal Cord Stimulation Market Restraints

The high costs of treatment and uneven distribution of medical service are hindering the market growth

  • The spinal cord stimulator implantations typically cost between US$ 21,000 and US$ 58,000. Whether the patient has private health insurance, public health insurance, or is footing the bill out of pocket also affects the cost of the surgery. In addition to this, the patient must cover yearly maintenance expenses such as hardware costs, healthcare workers' salaries, pulse generator replacement costs, hospitalization charges, etc. This is expected to most likely hinder the growth of the market.
  • Lack of availability of healthcare equipment at remote locations is expected to create a dearth of treatment options for local population. This is create dependency of local tribes to rely on bigger towns to avail the relevant medical treatment.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Spinal Cord Stimulation Market size was valued at USD 2.9 billion in 2022 and is poised to grow from USD 3.13 billion in 2023 to USD 5.7 billion by 2031, growing at a CAGR of 7.8% during the forecast period (2024-2031).

Due to the company's strong emphasis on research and development (R&D) as well as significant acquisitions that will help it in creating cutting-edge devices to manage chronic pain, Medtronic dominated the market by having accounting for a huge revenue share. Healthcare professionals prefer Medtronic spinal cord stimulators because they are easy to use, have long battery lives, produce superior clinical results, and come with outstanding customer support. 'Medtronic plc (Ireland) ', 'Boston Scientific Corporation (USA) ', 'Abbott Laboratories (USA) ', 'Nevro Corp. (USA) ', 'Stimwave Technologies, Inc. (USA) ', 'Saluda Medical Pty Ltd. (Australia) ', 'Synapse Biomedical Inc. (USA) ', 'Cirtec Medical (USA) ', 'Nalu Medical, Inc. (USA) ', 'Beijing PINS Medical Co., Ltd. (China) ', 'Gimer Medical (China) ', 'BIOTRONIK SE & Co. KG (Germany) ', 'St. Jude Medical, Inc. (acquired by Abbott) (USA) ', 'NeuroSigma, Inc. (USA) ', 'Greatbatch, Inc. (USA) ', 'Curonix LLC (USA) ', 'Teliatry, Inc. (USA) ', 'Spinal Modulation (USA) ', 'NevroSpin (USA) ', 'Axonics Modulation Technologies, Inc. (USA)'

The makers have intensified their research efforts in an effort to make spinal cord stimulators smaller. For instance, the Stimwave LCC-produced Freedom SCS system is roughly 5% smaller than the existing Implantable Pulse Generators (IPG) on the market. The rise of the spinal cord stimulation market is being driven by this as well as improvements in impulse production. 

Government Initiatives to Reduce Opioid Dependence: The governments of the U.S., Europe, and other countries have stepped up their efforts to lessen opioid dependence. Due to this, alternative therapies that do not need opioids are gradually becoming more popular, and demand for spinal cord stimulation devices is increasing. For instance, firms requesting a quick approval procedure for devices that can be used in place of opioids for pain management submitted more than 200 submissions to the FDA. In order to take advantage of this potential, medical device companies like Medtronic, Abbott, and Boston Scientific are constantly conducting research

North America is dominating the global market owing to market expansion as a result of new government regulations and favourable health reimbursement. The market in North America is being driven by the strategic presence of major competitors in the U.S. and new product launches.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Spinal Cord Stimulation Market

Report ID: SQMIG35A2711

$5,300
BUY NOW GET FREE SAMPLE